Uab Comprehensive Cancer Center

Birmingham, Alabama 35294-3410

3 studies enrolling now · 77 studies all time

What they study most

Actinic Keratosis, Acute Myelogenous Leukemia, Adrenocortical Carcinoma, Adult Glioblastoma Multiforme, Advanced Breast Carcinoma, Advanced Cancer, Advanced Multiple Myeloma, Advanced Ovarian Carcinoma, Anaplastic Astrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, B-Cell Malignancies, B-cell Malignancies

Studies at this site

• A Study of 177Lu-FAP-2286 in Advanced Solid Tumors — Recruiting now
• A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) — Recruiting now
• Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes? — Recruiting now
• A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• Endocrine Response in Women With Invasive Lobular Breast Cancer — Completed
• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling
• Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) — Running, not enrolling
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
• Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma — Running, not enrolling
• A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) — Completed
• S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Running, not enrolling
• Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer — Status unconfirmed
• BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations — Completed
• Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In — Completed
• Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG — Stopped early
• Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma — Stopped early
• An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread — Completed
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy — Completed
• Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas — Stopped early
• Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) — Completed
• Terameprocol in Treating Patients With Recurrent High Grade Glioma — Completed
• Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy — Status unconfirmed
• PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma — Completed
• Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer — Completed
• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy — Completed
• Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer — Completed
• Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial — Completed
• Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery — Completed
• High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery — Completed
• Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer — Completed
• Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma — Completed
• Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer — Completed
• The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors — Completed
• Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — Status unconfirmed
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma — Completed
• A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer — Completed
• Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM) — Completed
• Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia — Completed
• Pharmacokinetics of Daunorubicin in Young Patients With Cancer — Completed
• Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer — Completed
• Radiation Therapy in Treating Young Patients With Gliomas — Completed
• Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma — Completed
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery — Completed
• Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma — Completed
• A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents — Completed
• Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases — Stopped early